
Lepu Biopharma
Founded in Jan 2018 by Dr. Pu Zhongjie, Lepu Biotech focuses on tumor immunotherapy, R&D, production, and sales of targeted therapy drugs.
Market cap
$1.2b
Enterprise value
$1.2b
Share price
HKD5.40 2157.HK
Authorizing premium user...
Founded in Jan 2018 by Dr. Pu Zhongjie, Lepu Biotech focuses on tumor immunotherapy, R&D, production, and sales of targeted therapy drugs.